4-Hydroxy-N,N,2-trimethyl-1-((4-methylphenyl)sulfonyl)-1H-benzimidazole-6-carboxamide (CAS 942195-86-0) is used mainly as a key intermediate in the synthesis of Tegoprazan, a potassium-competitive acid blocker (P-CAB) used to treat acid-related gastrointestinal conditions like GERD and peptic ulcers, functioning as a precursor for more complex drug molecules.
4-Hydroxy-N,N,2-trimethyl-1-((4-methylphenyl)sulfonyl)-1H-benzimidazole-6-carboxamide
| API Name | Tegoprazan |
|---|---|
| CAS No | 942195-86-0 |
| Molecular Formula | C18H19N3O4S |
| Molecular Weight | 373.4 g/mol |
| Synonyms | 7-hydroxy-N,N,2-trimethyl-3-(4-methylphenyl)sulfonylbenzimidazole-5-carboxamide |
Zoho Contact Form
"*" indicates required fields